Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Intralipid. Always confirm against the full prescribing information.
38 interactions
Acenocoumarol
The therapeutic efficacy of Acenocoumarol can be decreased when used in combination with Soybean oil.
Level 1 evidence
Alteplase
The therapeutic efficacy of Alteplase can be decreased when used in combination with Soybean oil.
Level 1 evidence
Antithrombin Alfa
The therapeutic efficacy of Antithrombin Alfa can be decreased when used in combination with Soybean oil.
Level 1 evidence
Antithrombin III human
The therapeutic efficacy of Antithrombin III human can be decreased when used in combination with Soybean oil.
Level 1 evidence
Apixaban
The therapeutic efficacy of Apixaban can be decreased when used in combination with Soybean oil.
Level 1 evidence
Argatroban
The therapeutic efficacy of Argatroban can be decreased when used in combination with Soybean oil.
Level 1 evidence
Astaxanthin
The therapeutic efficacy of Astaxanthin can be decreased when used in combination with Soybean oil.
Level 1 evidence
Betrixaban
The therapeutic efficacy of Betrixaban can be decreased when used in combination with Soybean oil.
Level 1 evidence
Bivalirudin
The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Soybean oil.
Level 1 evidence
Brinase
The therapeutic efficacy of Brinase can be decreased when used in combination with Soybean oil.
Level 1 evidence
Cangrelor
The therapeutic efficacy of Cangrelor can be decreased when used in combination with Soybean oil.
Level 1 evidence
Dabigatran etexilate
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Soybean oil.
Intralipid (I. V. Fat Emulsion) has 38 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Intralipid (I. V. Fat Emulsion) has 0 major, 0 moderate, and 38 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Intralipid. Always confirm against the full prescribing information.